Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer. - Ji Lu; Kun Zhou; Xiaoxing Yin; Han Xu; Baojin Ma (Comput. Biol. Chem., 2019)